Have a personal or library account? Click to login
Treatment of Essential Tremor with Long-Chain Alcohols: Still Experimental or Ready for Prime Time? Cover

Treatment of Essential Tremor with Long-Chain Alcohols: Still Experimental or Ready for Prime Time?

Open Access
|Feb 2014

References

  1. 1
    LouisEDOttmanRHauserWAHow common is the most common adult movement disorder? Estimates of the prevalence of essential tremor throughout the worldMov Disord19981351010.1002/mds.8701301059452318
  2. 2
    LouisEDBarnesLAlbertSMet alCorrelates of functional disability in essential tremorMov Disord20011691492010.1002/mds.118411746622
  3. 3
    DeuschlGRaethjenJHellriegelHElbleRTreatment of patients with essential tremorLancet Neurol20111014816110.1016/S1474-4422(10)70322-721256454
  4. 4
    DeuschlGWenzelburgerRLöfflerKRaethjenJStolzeHEssential tremor and cerebellar dysfunction clinical and kinematic analysis of intention tremorBrain20001231568158010.1093/brain/123.8.156810908187
  5. 5
    KollerWCBusenbarkKMinerKThe relationship of essential tremor to other movement disorders: report on 678 patients. Essential Tremor Study GroupAnn Neurol19943571772310.1002/ana.4103506138210229
  6. 6
    LouJSJankovicJEssential tremor: clinical correlates in 350 patientsNeurology19914123423810.1212/WNL.41.2_Part_1.2341992367
  7. 7
    KnudsenKLorenzDDeuschlGA clinical test for the alcohol sensitivity of essential tremorMov Disord2011262291229510.1002/mds.2384622021159
  8. 8
    KlebeSStolzeHGrensingKVolkmannJWenzelburgerRDeuschlGInfluence of alcohol on gait in patients with essential tremorNeurology2005659610110.1212/01.wnl.0000167550.97413.1f16009892
  9. 9
    ZeunerKEMolloyFMShogeROGoldsteinSRWesleyRHallettMEffect of ethanol on the central oscillator in essential tremorMov Disord2003181280128510.1002/mds.1055314639668
  10. 10
    GrowdonJHShahaniBTYoungRRThe effect of alcohol on essential tremorNeurology19752525926210.1212/WNL.25.3.2591167633
  11. 11
    HarrisDPSinclairJGEthanol depresses inferior olive neurones and reduces Purkinje cell complex spike activity evoked by cerebral cortical stimulationGen Pharmacol19841545545910.1016/0306-3623(84)90199-X6526258
  12. 12
    LlinasRYaromYProperties and distribution of ionic conductances generating electroresponsiveness of mammalian inferior olivary neurones in vitroJ Physiol19813155695847310722
  13. 13
    MuJCardenWBKurukulasuriyaNCAlexanderGMGodwinDWEthanol influences on native T-type calcium current in thalamic sleep circuitryJ Pharmacol Exp Ther200330719720410.1124/jpet.103.05327212893844
  14. 14
    DupuisMJEvrardFLJacqueryePGPicardGRLermenOGDisappearance of essential tremor after strokeMov Disord2010252884288710.1002/mds.2332820836089
  15. 15
    RogersJMadambaSGStauntonDASigginsGREthanol increases single unit activity in the inferior olivary nucleusBrain Res198638525326210.1016/0006-8993(86)91071-13779391
  16. 16
    SoteloCLlinasRBakerRStructural study of inferior olivary nucleus of the cat: morphological correlates of electrotonic couplingJ Neurophysiol1974375415594827021
  17. 17
    OnizukaMHoangHKawatoMet alSolution to the inverse problem of estimating gap-junctional and inhibitory conductance in inferior olive neurons from spike trains by network model simulationNeural Netw201347516310.1016/j.neunet.2013.01.00623428796
  18. 18
    PlacantonakisDGBukovskyAAZengXHKiemHPWelshJPFundamental role of inferior olive connexin 36 in muscle coherence during tremorProc Natl Acad Sci U S A20041017164716910.1073/pnas.040032210115103021
  19. 19
    LongMADeansMRPaulDLConnorsBWRhythmicity without synchrony in the electrically uncoupled inferior oliveJ Neurosci200222108981090512486184
  20. 20
    MartinFCHandforthACarbenoxolone and mefloquine suppress tremor in the harmaline mouse model of essential tremorMov Disord2006211641164910.1002/mds.2094016773639
  21. 21
    FarrantMNusserZVariations on an inhibitory theme: phasic and tonic activation of GABA(A) receptorsNat Rev Neurosci2005621522910.1038/nrn162515738957
  22. 22
    BrickleySGCull-CandySGFarrantMDevelopment of a tonic form of synaptic inhibition in rat cerebellar granule cells resulting from persistent activation of GABAA receptorsJ Physiol19964977537599003560
  23. 23
    BaurRMinierFSigelEA GABA(A) receptor of defined subunit composition and positioning: concatenation of five subunitsFEBS Lett20065801616162010.1016/j.febslet.2006.02.00216494876
  24. 24
    GlykysJPengZChandraDHomanicsGEHouserCRModyIA new naturally occurring GABA(A) receptor subunit partnership with high sensitivity to ethanolNat Neurosci200710404810.1038/nn181317159992
  25. 25
    PirkerSSchwarzerCWieselthalerASieghartWSperkGGABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brainNeuroscience200010181585010.1016/S0306-4522(00)00442-511113332
  26. 26
    HancharHJDodsonPDOlsenRWOtisTSWallnerMAlcohol-induced motor impairment caused by increased extrasynaptic GABA(A) receptor activityNat Neurosci2005833934510.1038/nn139815696164
  27. 27
    DengHXieWJLeWDHuangMSJankovicJGenetic analysis of the GABRA1 gene in patients with essential tremorNeurosci Lett2006401161910.1016/j.neulet.2006.02.06616530959
  28. 28
    KralicJECriswellHEOstermanJLet alGenetic essential tremor in gamma-aminobutyric acidA receptor alpha1 subunit knockout miceJ Clin Invest200511577477915765150
  29. 29
    SchuckitMAMazzantiCSmithTLet alSelective genotyping for the role of 5-HT2A, 5-HT2C, and GABA alpha 6 receptors and the serotonin transporter in the level of response to alcohol: a pilot studyBiol Psychiatry19994564765110.1016/S0006-3223(98)00248-010088053
  30. 30
    RajputAHRobinsonCARajputAPurkinje cell loss is neither pathological basis nor characteristic of essential tremorParkinsonism Relat Disord20131949049110.1016/j.parkreldis.2012.11.01923312988
  31. 31
    LouisEDFaustPLVonsattelJPet alNeuropathological changes in essential tremor: 33 cases compared with 21 controlsBrain20071303297330710.1093/brain/awm26618025031
  32. 32
    LouisEDFaustPLVonsattelJPet alTorpedoes in Parkinson’s disease, Alzheimer’s disease, essential tremor, and control brainsMov Disord2009241600160510.1002/mds.2256719526585
  33. 33
    GrimaldiGMantoMIs essential tremor a Purkinjopathy? The role of the cerebellar cortex in its pathogenesisMov Disord2013281759176110.1002/mds.2564524114851
  34. 34
    LlinasMYaromYSpecific blockade of the low threshold calcium channel by high molecular weight alcoholsSoc Neurosci (Abstr)198612174
  35. 35
    SintonCMKrosserBIWaltonKDLlinásRRThe effectiveness of different isomers of octanol as blockers of harmaline-induced tremorPflugers Arch1989414313610.1007/BF005856232542888
  36. 36
    OpdykeDLFragrance raw materials monographs. Alcohol C-8Food Cosmet Toxicol19731110110.1016/0015-6264(73)90067-9
  37. 37
    JoksovicPMChoeWJNelsonMTOrestesPBrimelowBCTodorovicSMMechanisms of inhibition of T-type calcium current in the reticular thalamic neurons by 1-octanol: implication of the protein kinase C pathwayMol Pharmacol201077879410.1124/mol.109.05993119846748
  38. 38
    NahabFBHandforthABrownTet alOctanoic acid suppresses harmaline-induced tremor in mouse model of essential tremorNeurotherapeutics2012
  39. 39
    BusharaKOGoldsteinSRGrimesGJBursteinAHHallettMPilot trial of 1-octanol in essential tremorNeurology20046212212410.1212/01.WNL.0000101722.95137.1914718713
  40. 40
    ShillHABusharaKOMariZReichMHallettMOpen-label dose-escalation study of oral 1-octanol in patients with essential tremorNeurology2004622320232210.1212/WNL.62.12.232015210907
  41. 41
    NahabFBWittevrongelLIppolitoDet alAn open-label, single-dose, crossover study of the pharmacokinetics and metabolism of two oral formulations of 1-octanol in patients with essential tremorNeurotherapeutics2011875376210.1007/s13311-011-0045-121594724
  42. 42
    HaubenbergerDKalowitzDNahabFBet alValidation of digital spiral analysis as outcome parameter for clinical trials in essential tremorMov Disord2011262073208010.1002/mds.2380821714004
  43. 43
    LavadoESanchez-AbarcaLITaberneroABolanosJPMedinaJMOleic acid inhibits gap junction permeability and increases glucose uptake in cultured rat astrocytesJ Neurochem19976972172810.1046/j.1471-4159.1997.69020721.x9231732
  44. 44
    BachACBabayanVKMedium-chain triglycerides: An updateAm J Clin Nutr1982369509626814231
  45. 45
    OpdykeDLJMonograph—Caprylic acidFd Cosmet Toxicol19811923725410.1016/0015-6264(81)90363-1
  46. 46
    Council of Europe (COE)Chemically-defined flavouring substances; heptyl alcoholCouncil of Europe PublishingStrasbourg, France2000 p 48
  47. 47
    SchwabeADBennettLRBowmanLPOctanoic acid absorption and oxidation in humansJ Appl Physiol19641933533714155309
  48. 48
    OldendorfWHCarrier-mediated blood-brain barrier transport of short-chain monocarboxylic organic acidsAm J Physiol1973224145014534712154
  49. 49
    JennerPMHaganECTaylorJMCookELFitzhughOGFood flavourings and compounds of related structure I. Acute oral toxicityFood Cosm Toxicol1964232734310.1016/S0015-6264(64)80192-9
  50. 50
    TraulKADriedgerAIngleDLNakhasiDReview of the toxicologic properties of medium-chain triglyceridesFood Chem Toxicol200038799810.1016/S0278-6915(99)00106-410685018
  51. 51
    LinscherWGSloneDChalmersTCEffects of octanoic acid on serum-levels of free fatty acids, insulin, and glucose in patients with cirrhosis and in healthy volunteersLancet196759359710.1016/S0140-6736(67)90443-6
  52. 52
    SillsMAForsytheWIHaidukewychDRole of octanoic and decanoic acids in the control of seizuresArch Dis Child1986611173117710.1136/adc.61.12.11733492967
  53. 53
    SillsMAForsytheWIHaidukewychDMacDonaldARobinsonMThe medium chain triglyceride diet and intractable epilepsyArch Dis Child1986611168117210.1136/adc.61.12.11683101615
  54. 54
    CarnielliVPSulkersEJMorettiCet alConversion of octanoic acid into long-chain saturated fatty acids in premature infants fed a formula containing medium-chain triglyceridesMetab Clin Exp1994431287129210.1016/0026-0495(94)90224-07934982
  55. 55
    AshitaniJMatsumotoNNakazatoMEffect of octanoic acid-rich formula on plasma ghrelin levels in cachectic patients with chronic respiratory diseaseNutr J200982519527531
  56. 56
    GrosseSDKhouryMJGreeneCLCriderKSPollittRJThe epidemiology of medium chain acyl-CoA dehydrogenase deficiency: an updateGenet Med2006820521210.1097/01.gim.0000204472.25153.8d16617240
  57. 57
    DuranMMitchellGde KlerkJBet alOctanoic acidemia and octanoylcarnitine excretion with dicarboxylic aciduria due to defective oxidation of medium-chain fatty acidsJ Pediatr198510739740410.1016/S0022-3476(85)80514-X4032135
  58. 58
    NoctorTAWainerIWHageDSAllosteric and competitive displacement of drugs from human serum albumin by octanoic acid, as revealed by high-performance liquid affinity chromatography, on a human serum albumin-based stationary phaseJ Chromatogr199257730531510.1016/0378-4347(92)80252-L1400761
  59. 59
    HaubenbergerDMcCrossinGLunguCet alOctanoic acid in alcohol-responsive essential tremor: A randomized controlled studyNeurology2013
DOI: https://doi.org/10.5334/tohm.232 | Journal eISSN: 2160-8288
Language: English
Submitted on: Oct 10, 2013
Accepted on: Dec 31, 2013
Published on: Feb 5, 2014
Published by: Columbia University Libraries/Information Services
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2014 Dietrich Haubenberger, Fatta B. Nahab, Bernhard Voller, Mark Hallett, published by Columbia University Libraries/Information Services
This work is licensed under the Creative Commons License.